GANX - Gain Therapeutics Inc
IEX Last Trade
1.1
0.030 2.727%
Share volume: 555,763
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.07
0.03
2.80%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
Report Date | 2022-05-16 | 2022-08-08 | 2022-11-10 | 2023-03-23 | 2023-05-12 | 2023-08-10 | 2023-11-14 | 2024-03-26 | |
Cash flow financing | -37.974 K | 1.363 K | -20.581 K | -21.582 K | 748.908 K | 2.197 M | 134.473 K | 9.561 M | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash flow | -2.447 M | -5.051 M | -3.289 M | -3.905 M | -4.217 M | -5.021 M | -3.967 M | -5.660 M | |
Net income | -3.273 M | -5.085 M | -4.558 M | -4.674 M | -5.137 M | -7.688 M | -4.718 M | -4.724 M | |
Depreciation | 8.209 K | 20.021 K | 17.828 K | 18.110 K | 19.242 K | 20.239 K | 20.509 K | 23.589 K | |
Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Investing Cashflow | -7.825 K | -14.889 M | -11.411 K | 133.830 K | 2.107 M | 3.045 M | 1.929 M | 3.142 M | |
Net Borrowings | -34.897 M | -24.446 M | -23.080 M | -19.817 M | -18.116 M | -16.164 M | -12.203 M | -16.751 M | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | -7.825 K | -44.551 K | -57.179 K | -9.398 K | -11.045 K | -3.644 K | -650.000 | -19.000 | |
Cash Change | 34.339 M | 24.245 M | 22.730 M | 20.139 M | 17.816 M | 16.193 M | 12.233 M | 16.795 M |